Department of Pathology, Division of Molecular and Cellular Pathology, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Trends Endocrinol Metab. 2009 Nov;20(9):429-35. doi: 10.1016/j.tem.2009.06.004. Epub 2009 Oct 1.
Hyperglycemia and insulin resistance often occur following injury and/or critical illness. Whereas intensive insulin treatment reduces hyperglycemia, mortality and morbidity in certain patients, little is known regarding the pathophysiology of acute insulin resistance following injury and infection. Studies suggest that acute insulin resistance is complex and might differ in a tissue-specific manner, involving multiple causative factors and intracellular signaling pathways. Therefore, the advantages of intensive insulin therapy might not be uniform to all injuries or critical illnesses. Clearly, the increased incidence of hypoglycemic incidents following intensive insulin therapy indicates a need for understanding the underlying molecular mechanisms of the acute development of insulin resistance, which will allow a more targeted approach to treat altered glucose metabolism of critically ill patients.
高血糖和胰岛素抵抗在受伤和/或重病后经常发生。尽管强化胰岛素治疗可降低某些患者的高血糖、死亡率和发病率,但对于损伤和感染后急性胰岛素抵抗的病理生理学知之甚少。研究表明,急性胰岛素抵抗很复杂,可能以组织特异性的方式存在差异,涉及多种致病因素和细胞内信号通路。因此,强化胰岛素治疗的优势可能并非对所有损伤或重病都适用。显然,强化胰岛素治疗后低血糖事件发生率增加表明需要了解急性胰岛素抵抗发展的潜在分子机制,这将使我们能够更有针对性地治疗重症患者的葡萄糖代谢异常。